Literature DB >> 12208736

The candidate tumor suppressor ING1b can stabilize p53 by disrupting the regulation of p53 by MDM2.

Ka Man Leung1, Lai See Po, Fan Cheung Tsang, Wai Yi Siu, Anita Lau, Horace T B Ho, Randy Y C Poon.   

Abstract

ING1b is a candidate tumor suppressor that can stimulate the transcriptional activity of p53 and inhibit cell proliferation. The molecular basis of how ING1b activates p53 function remains unclear. Here we show that ING1b could stimulate the activity of p53 by increasing the level and stability of the p53 protein. The stabilization and activation of p53 by ING1b could be reversed by MDM2 in a dose-dependent manner. Conversely, ING1b could reverse the inhibition and degradation of p53 caused by MDM2 in a dose-dependent manner. Furthermore, ING1b and MDM2 bound to p53 in a mutually exclusive manner. In agreement with these observations, we found that similarly to MDM2, ING1b binds to the NH(2)-terminal region of p53. These data suggest a model in which ING1b disrupts the interaction between p53 and MDM2, leading to the stabilization of p53 and growth inhibition.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12208736

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  20 in total

1.  How many mutant p53 molecules are needed to inactivate a tetramer?

Authors:  Wan Mui Chan; Wai Yi Siu; Anita Lau; Randy Y C Poon
Journal:  Mol Cell Biol       Date:  2004-04       Impact factor: 4.272

2.  Genetic alterations and expression of inhibitor of growth 1 in human sporadic colorectal cancer.

Authors:  Li-Sheng Chen; Jian-Bao Wei; Yong-Chun Zhou; Sen Zhang; Jun-Lin Liang; Yun-Fei Cao; Zong-Jiang Tang; Xiao-Long Zhang; Feng Gao
Journal:  World J Gastroenterol       Date:  2005-10-21       Impact factor: 5.742

Review 3.  What has senescence got to do with cancer?

Authors:  Goberdhan P Dimri
Journal:  Cancer Cell       Date:  2005-06       Impact factor: 31.743

4.  Inhibitory effect of tumor suppressor p33(ING1b) and its synergy with p53 gene in hepatocellular carcinoma.

Authors:  Zhi Zhu; Jing Lin; Jian-Hui Qu; Mark-A Feitelson; Can-Rong Ni; Fang-Mei Li; Ming-Hua Zhu
Journal:  World J Gastroenterol       Date:  2005-04-07       Impact factor: 5.742

Review 5.  ING1 and ING2: multifaceted tumor suppressor genes.

Authors:  Claire Guérillon; Delphine Larrieu; Rémy Pedeux
Journal:  Cell Mol Life Sci       Date:  2013-02-15       Impact factor: 9.261

6.  Genetic alterations and reduced expression of tumor suppressor p33(ING1b) in human exocrine pancreatic carcinoma.

Authors:  Guan-Zhen Yu; Ming-Hua Zhu; Zhi Zhu; Can-Rong Ni; Jian-Ming Zheng; Fang-Mei Li
Journal:  World J Gastroenterol       Date:  2004-12-15       Impact factor: 5.742

7.  Subcellular targeting of p33ING1b by phosphorylation-dependent 14-3-3 binding regulates p21WAF1 expression.

Authors:  Wei Gong; Michael Russell; Keiko Suzuki; Karl Riabowol
Journal:  Mol Cell Biol       Date:  2006-04       Impact factor: 4.272

Review 8.  The ING gene family in the regulation of cell growth and tumorigenesis.

Authors:  Andrew H Coles; Stephen N Jones
Journal:  J Cell Physiol       Date:  2009-01       Impact factor: 6.384

9.  Histone H3K4me3 binding is required for the DNA repair and apoptotic activities of ING1 tumor suppressor.

Authors:  P V Peña; R A Hom; T Hung; H Lin; A J Kuo; R P C Wong; O M Subach; K S Champagne; R Zhao; V V Verkhusha; G Li; O Gozani; T G Kutateladze
Journal:  J Mol Biol       Date:  2008-05-02       Impact factor: 5.469

Review 10.  Critical pathways in cellular senescence and immortalization revealed by gene expression profiling.

Authors:  A L Fridman; M A Tainsky
Journal:  Oncogene       Date:  2008-08-18       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.